Experimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis)

Comparative Medicine

Volumn 60, Issue 5, 2010, Pages 380-388

  Appt, Susan E ^a   Clarkson, Thomas B ^a   Hoyer, Patricia B ^b   Kock, Nancy D ^a   Goode, Amanda K ^a   May, M Christina ^a   Persyn, Joseph T ^c   Vail, Neal K ^c   Ethun, Kelly F ^a   Chen, Haiying ^a   Sen, Nivedita ^b   Kaplan, Jay R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c SOUTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; ESTRADIOL; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLIMACTERIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; MACACA; NONHUMAN; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FOLLICLE CELL; POSTMENOPAUSE; PRIMORDIUM; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANTI-MULLERIAN HORMONE; CYCLOHEXENES; DISEASE MODELS, ANIMAL; FEMALE; MACACA FASCICULARIS; OVARIAN DISEASES; OVARIAN FOLLICLE; OVARY; SEXUAL DEVELOPMENT; VINYL COMPOUNDS;

EID: 78649407362     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adams MR, Kaplan JR, Clarkson TB, Koritnik DR. 1985. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 5:192-200.
2. Appt SE. 2008. Peer review continues forever. Fertil Steril 89:1034-1035.
3. Appt SE, Clarkson TB, Kaplan JR. 2010. Unpublished data.
4. Appt SE, Clarkson TB, Chen H, Adams MR, Christian PJ, Hoyer PB, Wilson ME, Kaplan JR. 2009. Serum antimüllerian hormone predicts ovarian reserve in a monkey model. Menopause 16:597-601.
5. Appt SE, Ethun KF. 2010. Reproductive aging and risk for chronic disease: Insights from studies of nonhuman primates. Maturitas 67:7-14.
6. Appt SE, Kaplan JR, Clarkson TB, Cline JM, Christian PJ, Hoyer PB. 2006. Destruction of primordial ovarian follicles in adult cynomolgus macaques after exposure to 4-vinylcyclohexene diepoxide: a nonhuman primate model of the menopausal transition. Fertil Steril 86:1210-1216.
7. Bachmann G. 2001. Physiologic aspects of natural and surgical menopause. J Reprod Med 46:307-315.
8. Bachmann GA, Leiblum SR. 2004. The impact of hormones on menopausal sexuality: a literature review. Menopause 11:120-130. (Pubitemid 40362209)
9. Bairey Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V, WISE Study Group. 2006. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause 85:1425-1431.
10. Bellino FL, Wise PM. 2003. Nonhuman primate models of menopause workshop. Biol Reprod 68:10-18. (Pubitemid 36076312)
11. Bernacky BJ, Gibson SV, Keeling ME, Abee CR. 2002. Nonhuman primates, p 675-791. In: Fox JG, Anderson LC, Loew FM, Quimby FW, editors. Laboratory animal medicine. Orlando (FL): Academic Press.
12. Burger HG, Hale GE, Dennerstein L, Robertson DM. 2008. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 15:603-612.
13. Burger HG, Hale GE, Robertson DM, Dennerstein L. 2007. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 13:559-565. (Pubitemid 350018524)
14. Clarkson TB, Anthony MS, Morgan TM. 2001. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effect of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86:41-47.
15. Clarkson TB, Anthony MS, Wagner JD. 2001. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 86:5396-5404. (Pubitemid 33070266)
16. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. 2006. Basal level of antimüllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 21:2022-2026. (Pubitemid 44288076)
17. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. 2007. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 92:3060-3067. (Pubitemid 47236371)
18. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, te Velde ER, Broekmans FJM. 2006. Antimüllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91:4057-4063.
19. Hoyer PB, Cannady EA, Kroeger NA, Sipes IG. 2001. Mechanisms of ovotoxicity induced by environmental chemicals: 4-vinylcyclohexene diepoxide as a model chemical, p 73-81. In: Dansette PM, editors. Biological reactive intermediates VI. New York (NY): Kluwer Academic/Plenum Publishers.
20. Hoyer PB, Devine PJ, Hu X, Thompson KE, Sipes IG. 2001. Ovarian toxicity of 4-vinylcyclohexene diepoxide: a mechanical model. Toxicol Pathol 29:91-99.
21. Hoyer PB, Sipes IG. 2007. Development of an animal model for ovotoxicity using 4-vinycyclohexene: a case study. Birth Defects Res B Dev Reprod Toxicol 80:113-125. (Pubitemid 46762320)
22. Hu X, Christian PJ, Thompson KE, Sipes IG, Hoyer PB. 2001. Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol Reprod 65:87-93. (Pubitemid 32574788)
23. Hu X, Roberts JR, Apopa PL, Kan YW, Ma Q. 2006. Accelerated ovarian failure induced by 4-vinylcyclohexene diepoxide in Nrf2-null mice. Mol Cell Biol 26:940-954. (Pubitemid 43146488)
24. Kao SW, Sipes IG, Hoyer PB. 1999. Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice. Reprod Toxicol 13:67-75.
25. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. 1995. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol 15:2094-2100.
26. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK. 1996. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 58:598-611.
27. Kaplan JR, Manuck SB, Anthony MS, Clarkson TB. 2002. Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol 99:381-388.
28. La Marca A, Stabile G, Carducci Artenisio A, Volpe A. 2006. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod 21:3103-3107. (Pubitemid 44811610)
29. Lee MM, Gustafson ML, Ukiyama E, Donahoe PK, MacLaughlin DT, Wexler M, Keeping HS. 1994. Developmental changes in müllerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis. J Clin Endocrinol Metab 78:615-621.
30. Lees CJ, Kaplan JR, Chen H, Jerome CP, Register TC, Franke AA. 2007. Bone mass and soy isoflavones in socially housed, premenopausal macaques. Am J Clin Nutr 86:245-250. (Pubitemid 47041617)
31. Lees CJ, Register TC, Turner CH, Wang T, Stancill M, Jerome CP. 2002. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biochemical measures in ovariectomized cynomolgus monkeys. Menopause 9:320-328. (Pubitemid 36701891)
32. Lobo RA. 1999. The perimenopause, p 43-45. In: Lobo RA, editor. Treatment of the postmenopausal woman. Philadelphia (PA): Lippincott-Raven Publishers.
33. Modi D, Bhartiya D, Puri C. 2006. Developmental expression and cellular distribution of Müllerian inhibiting substance in the primate ovary. Reproduction 132:443-453. (Pubitemid 44524508)
34. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. 2004. Inhibin B and antimullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 111:1248-1253.
35. NAMS Professional Education Committee. 2007. Overview of menopause and aging, p 9-17. In: Menopause practice: a clinician's guide. Mayfield Heights (OH): The North American Menopause Society.
36. Pal L, Bevilacqua K, Zeitlian G, Shu J, Santoro N. 2008. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause 15:1086-1094.
37. Pazol K, Wilson ME, Wallen K. 2004. Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques. J Clin Endocrinol Metab 89:2998-3006. (Pubitemid 38766400)
38. Pedersen T, Peters H. 1968. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17:555-557.
39. Register TC. 2009. Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis). Am J Primatol 71:766-775.
40. Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG. 2008. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause 15:1139-1144.
41. Sahambi SK, Visser JA, Themmen AP, Mayer LP, Devine PJ. 2008. Correlation of serum anti-Müllerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice. Reprod Toxicol 26:116-122.
42. Schuurman HJ, Smith HT. 2005. Reference values for clinical chemistry and clinical hematology parameters in cynomolgus monkeys. Xenotransplantation 12:72-75.
43. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph JF. 2008. Antimüllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 93:3478-3483.
44. Springer LN, Flaws JA, Sipes IG, Hoyer PB. 1996. Follicular mechanisms associated with 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Reprod Toxicol 10:137-143.
45. Springer LN, McAsey ME, Flaws JA, Tilly JL, Sipes IG, Hoyer PB. 1996. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol Appl Pharmacol 139:394-401.
46. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. 2008. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 90:395-400.
47. Thomas FH, Telfer EE, Fraser HM. 2007. Expression of antimullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. Endocrinology 148:2273-2281.
48. van Disseldorp J, Faddy MJ, Themmen APN, de Jong FH, Peeters PHM, van der Schouw YT, Broekmans FJM. 2008. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93:2129-2134.
49. van Rooij IAJ, den Tonkelaar I, Broekmans FJM, Looman CWN, Scheffer GJ, de Jong FH, Themmen APN, te Velde ER. 2004. Antimüllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11:601-606.
50. Visser JA, de Jong FH, Laven JSE, Themmen APN. 2006. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 131:1-9.
51. Visser JA, Themmen APN. 2005. Antimüllerian hormone and folliculogenesis. Mol Cell Endocrinol 234:81-86.
52. Wagner JD, Kavanagh K, Ward GM, Aurbach BJ, Harwood HJ Jr, Kaplan JR. 2006. Old world nonhuman primate models of type 2 diabetes mellitus. ILAR J 47:259-271. (Pubitemid 43986034)
53. Wagner JD, Zhang L, Shadoan MK, Kavanagh K, Chen H, Tresnasari K, Kaplan JR, Adams MR. 2008. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism 57:S24-S31.
54. Walker SE, Adams MR, Franke AA, Register TC. 2008. Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis 196:106-113.
55. Walker SE, Register TC, Appt SE, Adams M, Clarkson TB, Chen H, Isom S, Franke AA, Kaplan JR. 2008. Plasma lipid-dependent and -independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden. Menopause 15:950-957.
56. Wood CE, Kaplan JR, Stute P, Cline JM. 2006. Effects of soy on the mammary glands of premenopausal female monkeys. Fertil Steril 85:1179-1186.